Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -5.96
- Piotroski Score 2.00
- Grade Buy
- Symbol (DRIO)
- Company DarioHealth Corp.
- Price $0.80
- Changes Percentage (0.36%)
- Change -$0
- Day Low $0.80
- Day High $0.94
- Year High $2.60
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/26/2025
- Fiscal Year End N/A
- Average Stock Price Target $10.75
- High Stock Price Target $14.00
- Low Stock Price Target $7.50
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.68
- Trailing P/E Ratio -0.78
- Forward P/E Ratio -0.78
- P/E Growth -0.78
- Net Income $-59,427,000
Income Statement
Quarterly
Annual
Latest News of DRIO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
DarioHealth Corp. (NASDAQ:DRIO) Just Reported And Analysts Have Been Lifting Their Price Targets
DarioHealth Corp. (NASDAQ:DRIO) stock dropped 14% post quarterly results, with mixed revenue and smaller losses. Analysts predict a 39% revenue increase in 2024 and a 22% reduction in losses. Despite ...
By Yahoo! Finance | 3 months ago -
Is It Too Late To Consider Buying Kendrion N.V. (AMS:KENDR)?
Kendrion N.V. has shown significant share price fluctuations recently, prompting investors to consider if the current price of €12.58 accurately reflects its value. Despite an expensive price multip...
By Yahoo! Finance | 4 months ago
